{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:07:20Z","timestamp":1790096840865,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008126","name":"Jeju National University Hospital","doi-asserted-by":"crossref","award":["2013-15"],"award-info":[{"award-number":["2013-15"]}],"id":[{"id":"10.13039\/501100008126","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Seoul National University Hospital Research Fund","award":["03-2014-0380"],"award-info":[{"award-number":["03-2014-0380"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s13277-015-4231-3","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:41:04Z","timestamp":1446165664000},"page":"4743-4753","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"Min-Sun","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Lim","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yul Ri","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seock-Ah","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Suk","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"4231_CR1","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"key":"4231_CR2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1749-6632.2012.06762.x","volume":"1271","author":"NY Song","year":"2012","unstructured":"Song NY, Surh YJ. Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci. 2012;1271:10\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"4231_CR3","first-page":"1399","volume":"6","author":"H Yuan","year":"2013","unstructured":"Yuan H, Su L, Chen WY. The emerging and diverse roles of sirtuins in cancer: a clinical perspective. Onco Target Ther. 2013;6:1399\u2013416.","journal-title":"Onco Target Ther"},{"key":"4231_CR4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/onc.2008.388","volume":"28","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene. 2009;28:445\u201360.","journal-title":"Oncogene"},{"key":"4231_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/pros.22592","volume":"73","author":"JD Lovaas","year":"2013","unstructured":"Lovaas JD, Zhu L, Chiao CY, Byles V, Faller DV, Dai Y. SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells. Prostate. 2013;73:522\u201330.","journal-title":"Prostate"},{"key":"4231_CR6","first-page":"1726","volume":"27","author":"K Suzuki","year":"2012","unstructured":"Suzuki K, Hayashi R, Ichikawa T, Imanishi S, Yamada T, Inomata M, et al. SRT 1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice. Oncol Rep. 2012;27:1726\u201332.","journal-title":"Oncol Rep"},{"key":"4231_CR7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4132\/KoreanJPathol.2013.47.4.332","volume":"47","author":"W Jung","year":"2013","unstructured":"Jung W, Hong KD, Jung WY, Lee E, Shin BK, Kim HK, et al. SIRT1 expression is associated with good prognosis in colorectal cancer. Korean J Pathol. 2013;47:332\u20139.","journal-title":"Korean J Pathol"},{"key":"4231_CR8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4132\/KoreanJPathol.2012.46.6.523","volume":"46","author":"Y Kang","year":"2012","unstructured":"Kang Y, Jung WY, Lee H, Lee E, Kim A, Kim BH. Expression of SIRT1 and DBC1 in gastric adenocarcinoma. Korean J Pathol. 2012;46:523\u201331.","journal-title":"Korean J Pathol"},{"key":"4231_CR9","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.humpath.2012.10.001","volume":"44","author":"BC Dickson","year":"2013","unstructured":"Dickson BC, Riddle ND, Brooks JS, Pasha TL, Zhang PJ. Sirtuin 1 (SIRT1): a potential immunohistochemical marker and therapeutic target in soft tissue neoplasms with myoid differentiation. Hum Pathol. 2013;44:1125\u201330.","journal-title":"Hum Pathol"},{"key":"4231_CR10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.humpath.2010.05.023","volume":"42","author":"H Lee","year":"2011","unstructured":"Lee H, Kim KR, Noh SJ, Park HS, Kwon KS, Park BH, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. Hum Pathol. 2011;42:204\u201313.","journal-title":"Hum Pathol"},{"key":"4231_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3892\/or.2013.2470","volume":"30","author":"SJ Kuo","year":"2013","unstructured":"Kuo SJ, Lin HY, Chien SY, Chen DR. SIRT1 suppresses breast cancer growth through downregulation of the Bcl-2 protein. Oncol Rep. 2013;30:125\u201330.","journal-title":"Oncol Rep"},{"key":"4231_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/JOE-12-0102","volume":"216","author":"RL Moore","year":"2013","unstructured":"Moore RL, Faller DV. SIRT1 represses estrogen-signaling, ligand-independent ERalpha-mediated transcription, and cell proliferation in estrogen-responsive breast cells. J Endocrinol. 2013;216:273\u201385.","journal-title":"J Endocrinol"},{"key":"4231_CR13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"4231_CR14","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.humpath.2012.07.004","volume":"43","author":"HS Ryu","year":"2012","unstructured":"Ryu HS, Chung JH, Lee K, Shin E, Jing J, Choe G, et al. Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma. Hum Pathol. 2012;43:2360\u201370.","journal-title":"Hum Pathol"},{"key":"4231_CR15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.humpath.2011.07.003","volume":"43","author":"HS Ryu","year":"2012","unstructured":"Ryu HS, Park do J, Kim HH, Kim WH, Lee HS. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer. Hum Pathol. 2012;43:520\u20138.","journal-title":"Hum Pathol"},{"key":"4231_CR16","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/onc.2011.612","volume":"31","author":"V Byles","year":"2012","unstructured":"Byles V, Zhu L, Lovaas JD, Chmilewski LK, Wang J, Faller DV, et al. SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis. Oncogene. 2012;31:4619\u201329.","journal-title":"Oncogene"},{"key":"4231_CR17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1476-4598-13-254","volume":"13","author":"IC Chen","year":"2014","unstructured":"Chen IC, Chiang WF, Huang HH, Chen PF, Shen YY, Chiang HC. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer. 2014;13:254.","journal-title":"Mol Cancer"},{"key":"4231_CR18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.celrep.2013.03.019","volume":"3","author":"P Simic","year":"2013","unstructured":"Simic P, Williams EO, Bell EL, Gong JJ, Bonkowski M, Guarente L. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis. Cell Rep. 2013;3:1175\u201386.","journal-title":"Cell Rep"},{"key":"4231_CR19","doi-asserted-by":"crossref","first-page":"25992","DOI":"10.1074\/jbc.M111.229401","volume":"286","author":"G Eades","year":"2011","unstructured":"Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011;286:25992\u20136002.","journal-title":"J Biol Chem"},{"key":"4231_CR20","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","volume":"29","author":"A Singh","year":"2010","unstructured":"Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29:4741\u201351.","journal-title":"Oncogene"},{"key":"4231_CR21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403\u201310.","journal-title":"Histopathology"},{"key":"4231_CR22","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","volume":"28","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28:2784\u201395.","journal-title":"J Clin Oncol"},{"key":"4231_CR23","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","volume":"31","author":"AC Wolff","year":"2013","unstructured":"Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997\u20134013.","journal-title":"J Clin Oncol"},{"key":"4231_CR24","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.humpath.2015.03.015","volume":"46","author":"YR Chung","year":"2015","unstructured":"Chung YR, Kim H, Park SY, Park IA, Jang JJ, Choe JY, et al. Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype. Hum Pathol. 2015;46:1027\u201335.","journal-title":"Hum Pathol"},{"key":"4231_CR25","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1007\/s12032-012-0260-6","volume":"29","author":"M Wu","year":"2012","unstructured":"Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, et al. Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer. Med Oncol. 2012;29:3240\u20139.","journal-title":"Med Oncol"},{"key":"4231_CR26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.18632\/oncotarget.1070","volume":"4","author":"YW Yi","year":"2013","unstructured":"Yi YW, Kang HJ, Kim HJ, Kong Y, Brown ML, Bae I. Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells. Oncotarget. 2013;4:984\u201394.","journal-title":"Oncotarget"},{"key":"4231_CR27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1186\/1471-2407-14-978","volume":"14","author":"C Hao","year":"2014","unstructured":"Hao C, Zhu P, Yang X, Han Z, Jiang J, Zong C, et al. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma. BMC Cancer. 2014;14:978.","journal-title":"BMC Cancer"},{"key":"4231_CR28","first-page":"616","volume":"8","author":"YW Cao","year":"2015","unstructured":"Cao YW, Li YC, Wan GX, Du XM, Li F. Clinicopathological and prognostic role of SIRT1 in breast cancer patients: a meta-analysis. Int J Clin Exp Med. 2015;8:616\u201324.","journal-title":"Int J Clin Exp Med"},{"key":"4231_CR29","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.celrep.2014.07.049","volume":"8","author":"KM Atkins","year":"2014","unstructured":"Atkins KM, Thomas LL, Barroso-Gonzalez J, Thomas L, Auclair S, Yin J, et al. The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest. Cell Rep. 2014;8:1545\u201357.","journal-title":"Cell Rep"},{"key":"4231_CR30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/PAT.0b013e3283652c7a","volume":"45","author":"SJ Noh","year":"2013","unstructured":"Noh SJ, Kang MJ, Kim KM, Bae JS, Park HS, Moon WS, et al. Acetylation status of p53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients. Pathology. 2013;45:574\u201380.","journal-title":"Pathology"},{"key":"4231_CR31","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1593\/neo.09470","volume":"11","author":"RC Tseng","year":"2009","unstructured":"Tseng RC, Lee CC, Hsu HS, Tzao C, Wang YC. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients. Neoplasia. 2009;11:763\u201370.","journal-title":"Neoplasia"},{"key":"4231_CR32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149\u201359.","journal-title":"Cell"},{"key":"4231_CR33","doi-asserted-by":"crossref","unstructured":"Sasaki T, Maier B, Koclega KD, Chruszcz M, Gluba W, Stukenberg PT, et al. Phosphorylation regulates SIRT1 function. PLoS One. 2008;3:e4020.","DOI":"10.1371\/journal.pone.0004020"},{"key":"4231_CR34","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.1073\/pnas.0932692100","volume":"100","author":"T Sorlie","year":"2003","unstructured":"Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4231_CR35","first-page":"211","volume":"4","author":"BJ Hwang","year":"2014","unstructured":"Hwang BJ, Madabushi A, Jin J, Lin SY, Lu AL. Histone\/protein deacetylase SIRT1 is an anticancer therapeutic target. Am J Cancer Res. 2014;4:211\u201321.","journal-title":"Am J Cancer Res"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4231-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4231-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4231-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T01:49:45Z","timestamp":1589593785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4231-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["4231"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4231-3","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]}}}